PFIZER INC Quarterly Debt-to-equity in % from Q4 2010 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Pfizer Inc quarterly Debt-to-equity history and growth rate from Q4 2010 to Q3 2024.
  • Pfizer Inc Debt-to-equity for the quarter ending September 29, 2024 was 144 %, a 30.3% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 144 +33.5 +30.3% Sep 29, 2024
Q2 2024 140 +32 +29.6% Jun 30, 2024
Q1 2024 134 +25.9 +24% Mar 31, 2024
Q4 2023 122 +6.55 +5.68% Dec 31, 2023
Q3 2023 111 -11.7 -9.59% Oct 1, 2023
Q2 2023 108 -21.1 -16.4% Jul 2, 2023
Q1 2023 108 -25.8 -19.3% Apr 2, 2023
Q4 2022 115 -20.8 -15.3% Dec 31, 2022
Q3 2022 122 -15.8 -11.4% Oct 2, 2022
Q2 2022 129 -18.4 -12.5% Jul 3, 2022
Q1 2022 134 -22.3 -14.3% Apr 3, 2022
Q4 2021 136 -26.3 -16.2% Dec 31, 2021
Q3 2021 138 -29.4 -17.6% Oct 3, 2021
Q2 2021 147 -17 -10.4% Jul 4, 2021
Q1 2021 156 -4.88 -3.04% Apr 4, 2021
Q4 2020 162 -0.56 -0.34% Dec 31, 2020
Q3 2020 168 +8.31 +5.22% Sep 27, 2020
Q2 2020 164 +12.6 +8.27% Jun 28, 2020
Q1 2020 161 +15.3 +10.5% Mar 29, 2020
Q4 2019 163 +24.3 +17.5% Dec 31, 2019
Q3 2019 159 +23 +16.8% Sep 29, 2019
Q2 2019 152 +4.79 +3.26% Jun 30, 2019
Q1 2019 145 -13.8 -8.68% Mar 31, 2019
Q4 2018 139 -34.6 -20% Dec 31, 2018
Q3 2018 136 -50.4 -27% Sep 30, 2018
Q2 2018 147 -39.2 -21.1% Jul 1, 2018
Q1 2018 159 -22.8 -12.5% Apr 1, 2018
Q4 2017 173 -1.22 -0.7% Dec 31, 2017
Q3 2017 187 +19.5 +11.7% Oct 1, 2017
Q2 2017 186 +25.7 +16% Jul 2, 2017
Q1 2017 182 +29.3 +19.2% Apr 2, 2017
Q4 2016 174 +26.6 +18% Dec 31, 2016
Q3 2016 167 +25.3 +17.8% Oct 2, 2016
Q2 2016 161 +28 +21.1% Jul 3, 2016
Q1 2016 153 +23.9 +18.6% Apr 3, 2016
Q4 2015 148 +23.2 +18.6% Dec 31, 2015
Q3 2015 142 +19.5 +15.9% Sep 27, 2015
Q2 2015 133 +8.78 +7.09% Jun 28, 2015
Q1 2015 129 +4.29 +3.45% Mar 29, 2015
Q4 2014 125 -1.59 -1.26% Dec 31, 2014
Q3 2014 122 -4.5 -3.55% Sep 28, 2014
Q2 2014 124 -2.73 -2.16% Jun 29, 2014
Q1 2014 125 -2.36 -1.86% Mar 30, 2014
Q4 2013 126 +0.48 +0.38% Dec 31, 2013
Q3 2013 127 +1.2 +0.95% Sep 29, 2013
Q2 2013 126 +2.37 +1.91% Jun 30, 2013
Q1 2013 127 +4.8 +3.93% Mar 31, 2013
Q4 2012 126 +5.3 +4.4% Dec 31, 2012
Q3 2012 126 +6.85 +5.76% Sep 30, 2012
Q2 2012 124 +5.07 +4.26% Jul 1, 2012
Q1 2012 122 +3.11 +2.61% Apr 1, 2012
Q4 2011 120 +1.12 +0.94% Dec 31, 2011
Q3 2011 119 Oct 2, 2011
Q2 2011 119 Jul 3, 2011
Q1 2011 119 Apr 3, 2011
Q4 2010 119 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.